Immunomodulating activities of orally administered SMANCS, a polymer-conjugated derivative of the proteinaceous antibiotic neocarzinostatin, in an oily formulation

Suzuki Fujio Suzuki, Matsumoto Kaori Matsumoto, David A. Schmitt, Richard B Pollard, Maeda Hiroshi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Immunomodulatory effects of oily formulated SMANCS, a polymer conjugated derivative of the proteinsceous antibiotic neocarzinostatin, after oral administrations to mice was investigated. The oral administrations of SMANCS, dissolved in medium-chain triglyceride containing phosphatidylcholine and polyglycerine dioleate (oily SMANCS), resulted in: (1) augmentation of NK cell activity in naive mice, (2) activation of macrophage cytostasis in naive mice, (3) enhancement of the generation of cytotoxic T-lymphocytes in mice immunized with allogeneic lymphocytes, (4) production of circulating interferon in naive mice, and (5) increase of delayed-type hypersensitivity response in mice immunized with sheep red blood cells. The degree of immunomodulation orally stimulated with oily SMANCS was similar to that of the immunomodulation induced by i.v. or i.p. administrations of aqueous formulated SMANCS (aqueous SMANCS). Although SMANCS is a protein drug that may be digestable by various enzymes present in the stomach, in the present study immunomodulating activities of SMANCS were clearly demonstrated when an oily formulation of the compound was administered to mice orally. Since aqueous SMANCS administered parenterally and oily SMANCS administered orally exhibit the same immunomodulatory activities and the former has demonstrated antitumor activity in man and animals, the latter may possess this same antitumor activity.

Original languageEnglish (US)
Pages (from-to)175-183
Number of pages9
JournalInternational Journal of Immunopharmacology
Volume15
Issue number2
DOIs
StatePublished - 1993
Externally publishedYes

Fingerprint

Zinostatin
Polymers
Anti-Bacterial Agents
Immunomodulation
Oral Administration
poly(maleic acid-styrene)neocarzinostatin
Macrophage Activation
Delayed Hypersensitivity
Cytotoxic T-Lymphocytes
Phosphatidylcholines
Natural Killer Cells
Interferons
Sheep
Stomach
Triglycerides
Erythrocytes

ASJC Scopus subject areas

  • Immunology
  • Pharmacology

Cite this

Immunomodulating activities of orally administered SMANCS, a polymer-conjugated derivative of the proteinaceous antibiotic neocarzinostatin, in an oily formulation. / Fujio Suzuki, Suzuki; Kaori Matsumoto, Matsumoto; Schmitt, David A.; Pollard, Richard B; Hiroshi, Maeda.

In: International Journal of Immunopharmacology, Vol. 15, No. 2, 1993, p. 175-183.

Research output: Contribution to journalArticle

@article{e3239097c2c64ea0a47da7a2d0ed246c,
title = "Immunomodulating activities of orally administered SMANCS, a polymer-conjugated derivative of the proteinaceous antibiotic neocarzinostatin, in an oily formulation",
abstract = "Immunomodulatory effects of oily formulated SMANCS, a polymer conjugated derivative of the proteinsceous antibiotic neocarzinostatin, after oral administrations to mice was investigated. The oral administrations of SMANCS, dissolved in medium-chain triglyceride containing phosphatidylcholine and polyglycerine dioleate (oily SMANCS), resulted in: (1) augmentation of NK cell activity in naive mice, (2) activation of macrophage cytostasis in naive mice, (3) enhancement of the generation of cytotoxic T-lymphocytes in mice immunized with allogeneic lymphocytes, (4) production of circulating interferon in naive mice, and (5) increase of delayed-type hypersensitivity response in mice immunized with sheep red blood cells. The degree of immunomodulation orally stimulated with oily SMANCS was similar to that of the immunomodulation induced by i.v. or i.p. administrations of aqueous formulated SMANCS (aqueous SMANCS). Although SMANCS is a protein drug that may be digestable by various enzymes present in the stomach, in the present study immunomodulating activities of SMANCS were clearly demonstrated when an oily formulation of the compound was administered to mice orally. Since aqueous SMANCS administered parenterally and oily SMANCS administered orally exhibit the same immunomodulatory activities and the former has demonstrated antitumor activity in man and animals, the latter may possess this same antitumor activity.",
author = "{Fujio Suzuki}, Suzuki and {Kaori Matsumoto}, Matsumoto and Schmitt, {David A.} and Pollard, {Richard B} and Maeda Hiroshi",
year = "1993",
doi = "10.1016/0192-0561(93)90093-E",
language = "English (US)",
volume = "15",
pages = "175--183",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Immunomodulating activities of orally administered SMANCS, a polymer-conjugated derivative of the proteinaceous antibiotic neocarzinostatin, in an oily formulation

AU - Fujio Suzuki, Suzuki

AU - Kaori Matsumoto, Matsumoto

AU - Schmitt, David A.

AU - Pollard, Richard B

AU - Hiroshi, Maeda

PY - 1993

Y1 - 1993

N2 - Immunomodulatory effects of oily formulated SMANCS, a polymer conjugated derivative of the proteinsceous antibiotic neocarzinostatin, after oral administrations to mice was investigated. The oral administrations of SMANCS, dissolved in medium-chain triglyceride containing phosphatidylcholine and polyglycerine dioleate (oily SMANCS), resulted in: (1) augmentation of NK cell activity in naive mice, (2) activation of macrophage cytostasis in naive mice, (3) enhancement of the generation of cytotoxic T-lymphocytes in mice immunized with allogeneic lymphocytes, (4) production of circulating interferon in naive mice, and (5) increase of delayed-type hypersensitivity response in mice immunized with sheep red blood cells. The degree of immunomodulation orally stimulated with oily SMANCS was similar to that of the immunomodulation induced by i.v. or i.p. administrations of aqueous formulated SMANCS (aqueous SMANCS). Although SMANCS is a protein drug that may be digestable by various enzymes present in the stomach, in the present study immunomodulating activities of SMANCS were clearly demonstrated when an oily formulation of the compound was administered to mice orally. Since aqueous SMANCS administered parenterally and oily SMANCS administered orally exhibit the same immunomodulatory activities and the former has demonstrated antitumor activity in man and animals, the latter may possess this same antitumor activity.

AB - Immunomodulatory effects of oily formulated SMANCS, a polymer conjugated derivative of the proteinsceous antibiotic neocarzinostatin, after oral administrations to mice was investigated. The oral administrations of SMANCS, dissolved in medium-chain triglyceride containing phosphatidylcholine and polyglycerine dioleate (oily SMANCS), resulted in: (1) augmentation of NK cell activity in naive mice, (2) activation of macrophage cytostasis in naive mice, (3) enhancement of the generation of cytotoxic T-lymphocytes in mice immunized with allogeneic lymphocytes, (4) production of circulating interferon in naive mice, and (5) increase of delayed-type hypersensitivity response in mice immunized with sheep red blood cells. The degree of immunomodulation orally stimulated with oily SMANCS was similar to that of the immunomodulation induced by i.v. or i.p. administrations of aqueous formulated SMANCS (aqueous SMANCS). Although SMANCS is a protein drug that may be digestable by various enzymes present in the stomach, in the present study immunomodulating activities of SMANCS were clearly demonstrated when an oily formulation of the compound was administered to mice orally. Since aqueous SMANCS administered parenterally and oily SMANCS administered orally exhibit the same immunomodulatory activities and the former has demonstrated antitumor activity in man and animals, the latter may possess this same antitumor activity.

UR - http://www.scopus.com/inward/record.url?scp=0027512350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027512350&partnerID=8YFLogxK

U2 - 10.1016/0192-0561(93)90093-E

DO - 10.1016/0192-0561(93)90093-E

M3 - Article

C2 - 7682198

AN - SCOPUS:0027512350

VL - 15

SP - 175

EP - 183

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

IS - 2

ER -